Pulmonary Sarcoidosis on PET-CT: Interpretation Guide

Pulmonary sarcoidosis is a granulomatous lung disease that often shows up on PET-CT looking remarkably like Hodgkin lymphoma. Bilateral hilar and mediastinal lymphadenopathy with intense FDG uptake — the same pattern in both diseases. PET-CT plays an important role both in initial diagnosis (often via biopsy guidance) and in monitoring treatment response. This guide explains what sarcoidosis looks like on PET and how to interpret its findings.

What Sarcoidosis Looks Like on PET

Classic pulmonary sarcoidosis findings on FDG PET-CT:

• Bilateral hilar lymph node FDG uptake (intense, symmetric)
• Bilateral mediastinal node uptake (paratracheal, subcarinal stations)
• Sometimes lung parenchymal uptake in fibrotic or nodular forms
• Sometimes splenic uptake if systemic involvement
• Sometimes skin, eye, or other organ uptake

The bilateral symmetric hilar pattern is highly suggestive of sarcoidosis when combined with consistent clinical features (Asian, African-American, or Scandinavian descent; characteristic age 20–40; non-caseating granulomas on biopsy).

Classic Bilateral Hilar Lymphadenopathy

Stage I sarcoidosis (radiographic):
- Bilateral hilar lymphadenopathy
- No parenchymal lung disease
- Sometimes asymptomatic; often incidental finding on chest X-ray
- Excellent prognosis with spontaneous resolution in most patients

On PET-CT, this presents as intensely FDG-avid bilateral hilar and mediastinal nodes. SUVmax often 8–25.

The PET pattern alone cannot distinguish sarcoidosis from lymphoma — both look similar. Tissue biopsy (endobronchial ultrasound-guided fine needle aspiration of a mediastinal node) provides definitive diagnosis.

Mediastinal Node FDG Uptake

Sarcoidosis affects multiple node stations:

• Subcarinal (station 7) — frequent
• Paratracheal (stations 2R, 2L, 4R, 4L) — common
• Hilar (stations 10–11) — bilateral typical
• Aortopulmonary window (station 5) — common
• Subaortic (station 6) — less common

SUVmax in active sarcoidosis nodes: 8–20 typically. Both treatment-responsive and untreated active disease shows high uptake.

Differentiating from Lymphoma

Features that favor sarcoidosis over lymphoma:

• Bilateral symmetric hilar enlargement
• Multiple lymph node stations involved
• Splenic involvement without bulky abdominal nodes
• Skin or eye involvement
• Asymptomatic finding (sarcoidosis often incidental)
• Elevated ACE (angiotensin-converting enzyme), elevated lysozyme

Features that favor lymphoma:

• Unilateral or asymmetric nodes
• Bulky abdominal involvement
• B-symptoms (fever, night sweats, weight loss >10%)
• Mediastinal mass with displacement
• Single dominant node mass

Definitive distinction requires biopsy and histology.

Monitoring Steroid Response

Sarcoidosis treatment typically involves corticosteroids (prednisone 20–40 mg/day) for 6–12 months in symptomatic patients. PET-CT can track response:

• Pre-treatment baseline PET: documents active inflammation
• Repeat PET 3–6 months post-treatment: response if FDG uptake significantly reduced
• Long-term follow-up: PET every 1–2 years if continuing immunosuppression

A successful response: focal FDG uptake resolves or markedly decreases. Persistent uptake despite steroid treatment suggests treatment failure or atypical disease.

For sarcoidosis vs lymphoma diagnostic workup, our team can help.

When to Repeat PET

Indications for repeat PET-CT in known sarcoidosis:

• 3–6 months post-treatment to assess response
• At symptom flare or new clinical findings
• Before treatment de-escalation (confirms quiescence)
• Suspected new disease activity (rising biomarkers, new imaging changes)

For asymptomatic patients with stable disease, routine surveillance PET is generally NOT indicated — the radiation exposure isn't justified for stable disease.

Patient Pathway in China

Top Chinese centers for sarcoidosis evaluation:

• Shanghai Pulmonary Hospital — largest pulmonary referral center in China
• PUMC Beijing — academic and clinical immunology
• Fudan Pulmonary Hospital — comprehensive pulmonary
• Sun Yat-sen Memorial Pulmonology — regional referral

International patient pathway:

1. Send prior imaging (CT, PET, chest X-rays), pathology slides, labs (ACE, lysozyme, calcium)
2. Pre-arrival video consult with pulmonology
3. Arrival day 1: pulmonary consultation, repeat labs if needed
4. Day 2: PET-CT, possibly with biopsy
5. Day 3: results and treatment plan
6. Day 4: departure

Cost: ¥6,500–9,000 for PET-CT; ¥4,000–8,000 for bronchoscopy + EBUS biopsy if needed; specialist consultation ¥600–1,500.

Need Help Booking?

SinoCareLink can pre-book PET-CT, bronchoscopy, and pulmonology consultation at a top Chinese hospital for sarcoidosis workup, translate reports into English, and arrange airport pickup. Contact us for a free consultation.